Pembrolizumab Induced Acute Persistent Airway Disease in a Patient with Recurrent Respiratory Papillomatosis (RRP).

Kathryn S MarcusDaniel J LeeJeffrey S WilsonRichard J H SmithMichael D Puricelli

Published in: The Annals of otology, rhinology, and laryngology (2021)

To our knowledge, this case is the first report of pembrolizumab-induced obstructive respiratory failure in a patient being treated for RRP.

Keyphrases